{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T19:51:11Z","timestamp":1793994671487,"version":"4.8.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008402","name":"U.S. Consumer Product Safety Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008402","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajpm-online.net","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Preventive Medicine"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.amepre.2023.01.011","type":"journal-article","created":{"date-parts":[[2023,4,20]],"date-time":"2023-04-20T04:29:05Z","timestamp":1681964945000},"page":"834-843","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Trends in Emergency Department Visits for Unsupervised Pediatric Medication Exposures"],"prefix":"10.1016","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9627-2059","authenticated-orcid":false,"given":"Maribeth C.","family":"Lovegrove","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina J.","family":"Weidle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew I.","family":"Geller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7408-3318","authenticated-orcid":false,"given":"Jennifer N.","family":"Lind","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen O.","family":"Rose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra K.","family":"Goring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel S.","family":"Budnitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amepre.2023.01.011_bib0001","unstructured":"Subchapter E\u2014poison prevention packaging act of 1970 regulations, Part 1700\u2014Poison Prevention Packaging. Code of Federal Regulations. https:\/\/www.govinfo.gov\/content\/pkg\/CFR-2012-title16-vol2\/pdf\/CFR-2012-title16-vol2-part1700.pdf. Accessed November 3, 2022."},{"issue":"2","key":"10.1016\/j.amepre.2023.01.011_bib0002","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jpeds.2011.07.042","article-title":"The growing impact of pediatric pharmaceutical poisoning [published correction appears in J Pediatr. 2012;160(5):888\u2013889]","volume":"160","author":"Bond","year":"2012","journal-title":"J Pediatr"},{"issue":"4","key":"10.1016\/j.amepre.2023.01.011_bib0003","doi-asserted-by":"crossref","first-page":"e821","DOI":"10.1542\/peds.2015-2092","article-title":"Trends in emergency department visits for unsupervised pediatric medication exposures, 2004\u20132013","volume":"136","author":"Lovegrove","year":"2015","journal-title":"Pediatrics"},{"issue":"6","key":"10.1016\/j.amepre.2023.01.011_bib0004","doi-asserted-by":"crossref","first-page":"e1597","DOI":"10.1542\/peds.2011-0926","article-title":"Preventing medication overdoses in young children: an opportunity for harm elimination","volume":"127","author":"Budnitz","year":"2011","journal-title":"Pediatrics"},{"key":"10.1016\/j.amepre.2023.01.011_bib0005","unstructured":"Put your medicines up and away and out of sight. UpAndAway.org. https:\/\/upandaway.org\/. Updated January 2023. Accessed November 3, 2022."},{"key":"10.1016\/j.amepre.2023.01.011_bib0006","unstructured":"Safe kids worldwide. Medication safety. https:\/\/www.safekids.org\/medicinesafety?msclkid=6dc4427ea54d11ecb2f7d468eff8d401. Updated 2023. Accessed November 3, 2022."},{"issue":"6","key":"10.1016\/j.amepre.2023.01.011_bib0007","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1001\/jama.2020.2152","article-title":"Prevention of unintentional medication overdose among children: time for the promise of the poison prevention packaging act to come to fruition","volume":"324","author":"Budnitz","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.amepre.2023.01.011_bib0008","unstructured":"Reduce emergency department visits for medication overdoses in children under 5 years\u2014MPS01. Healthy People 2030, HHS, Office of Disease Prevention and Health Promotion.https:\/\/health.gov\/healthypeople\/objectives-and-data\/browse-objectives\/hospital-and-emergency-services\/reduce-emergency-department-visits-medication-overdoses-children-under-5-years-mps-01. Updated 2021. Accessed March 17, 2023."},{"issue":"10","key":"10.1016\/j.amepre.2023.01.011_bib0009","doi-asserted-by":"crossref","first-page":"S96","DOI":"10.1097\/MLR.0b013e318041f737","article-title":"Evaluation and overview of the National Electronic Injury Surveillance System-Cooperative Adverse Drug Event Surveillance Project (NEISS-CADES)","volume":"45","author":"Jhung","year":"2007","journal-title":"Med Care"},{"issue":"13","key":"10.1016\/j.amepre.2023.01.011_bib0010","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1001\/jama.2021.13844","article-title":"U.S. Emergency Department visits attributed to medication harms, 2017\u20132019","volume":"326","author":"Budnitz","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.amepre.2023.01.011_bib0011","unstructured":"Centers for Disease Control and Prevention (CDC). National estimates of nonfatal injuries treated in hospital emergency departments\u2013United States, 2000. MMWR Morb Mortal Wkly Rep. 2001;50(17):340\u2013346. https:\/\/www.cdc.gov\/mmwr\/preview\/mmwrhtml\/mm5017a4.htm. Accessed November 3, 2022."},{"key":"10.1016\/j.amepre.2023.01.011_bib0012","unstructured":"United States Government, Federal regulations and codes. see e.g., 45 C.F.R. part 46.102(l)(2), 21 C.F.R.;56; 42 U.S.C. \u00a7241(d); 5 U.S.C. \u00a7552a; 44 U.S.C. \u00a73501 et seq."},{"key":"10.1016\/j.amepre.2023.01.011_bib0013","unstructured":"Facts and Comparisons\u00ae. Wolters Kluwer. https:\/\/www.wolterskluwer.com\/en\/solutions\/lexicomp\/facts-and-comparisons. Updated 2023. Accessed November 3, 2022."},{"key":"10.1016\/j.amepre.2023.01.011_bib0014","unstructured":"Approved drug products with therapeutic equivalence evaluations | Orange book. U.S. Food and Drug Administration.https:\/\/www.fda.gov\/drugs\/drug-approvals-and-databases\/approved-drug-products-therapeutic-equivalence-evaluations-orange-book#:\u223c:text=The%20publication%20Approved%20Drug%20Products,Act)%20and%20related%20patent%20and. Updated December 9, 2022. Accessed February 3, 2023."},{"key":"10.1016\/j.amepre.2023.01.011_bib0015","unstructured":"WISQARS\u2122\u2014web-based injury statistics query and reporting system. Centers for Disease Control and Prevention. https:\/\/www.cdc.gov\/injury\/wisqars\/index.html. Updated December 2, 2021. Accessed November 3, 2022."},{"key":"10.1016\/j.amepre.2023.01.011_bib0016","unstructured":"Schroeder T, Ault K. The NEISS sample (design and implementation) 1997 to present.https:\/\/www.cpsc.gov\/s3fs-public\/pdfs\/blk_media_2001d011-6b6.pdf. Accessed February 3, 2023."},{"key":"10.1016\/j.amepre.2023.01.011_bib0017","unstructured":"Centers for Disease Control and Prevention. National Center for Injury Prevention and Control, and U.S. Consumer Product Safety Commission. National Electronic Injury Surveillance System All Injury Program, 2019. Ann Arbor, MI: Inter-university Consortium for Political and Social Research. https:\/\/www.icpsr.umich.edu\/web\/NACJD\/studies\/38289\/datadocumentation. Published December 15, 2021. Accessed November 3, 2022."},{"issue":"3","key":"10.1016\/j.amepre.2023.01.011_bib0018","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z","article-title":"Permutation tests for joinpoint regression with applications to cancer rates [published correction appears in Stat Med. 2001;20(4):655]","volume":"19","author":"Kim","year":"2000","journal-title":"Stat Med"},{"issue":"10","key":"10.1016\/j.amepre.2023.01.011_bib0019","doi-asserted-by":"crossref","first-page":"979","DOI":"10.3109\/15563650.2010.543906","article-title":"Annual report of the American Association of Poison Control Centers\u2019 National Poison Data System (NPDS): 27th Annual Report [published correction appears in Clin Toxicol (Phila). 2014;52(10):1284]","volume":"48","author":"Bronstein","year":"2010","journal-title":"Clin Toxicol (Phila)"},{"issue":"12","key":"10.1016\/j.amepre.2023.01.011_bib0020","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1080\/15563650.2021.1989785","article-title":"2020 Annual report of the American Association of Poison Control Centers\u2019 National Poison Data System (NPDS): 38th Annual Report","volume":"59","author":"Gummin","year":"2021","journal-title":"Clin Toxicol (Phila)"},{"key":"10.1016\/j.amepre.2023.01.011_bib0021","unstructured":"PROTECT safety improvements. Centers for Disease Control and Prevention. https:\/\/www.cdc.gov\/medicationsafety\/protect\/accomplishments.html. Updated October 2017. Accessed November 3, 2022."},{"issue":"2","key":"10.1016\/j.amepre.2023.01.011_bib0022","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/pds.5384","article-title":"US Emergency Department visits for acute harms from over-the-counter cough and cold medications, 2017\u20132019","volume":"31","author":"Mital","year":"2022","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.amepre.2023.01.011_bib0023","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.jpeds.2018.02.033","article-title":"Frequency of poison center exposures for pediatric accidental unsupervised ingestions of acetaminophen after the introduction of flow restrictors","volume":"198","author":"Brass","year":"2018","journal-title":"J Pediatr"},{"issue":"6","key":"10.1016\/j.amepre.2023.01.011_bib0024","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1542\/peds.2013-2236","article-title":"Cough and cold medication adverse events after market withdrawal and labeling revision","volume":"132","author":"Hampton","year":"2013","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.amepre.2023.01.011_bib0025","doi-asserted-by":"crossref","first-page":"e100","DOI":"10.1097\/PEC.0000000000002166","article-title":"Adverse events related to accidental unintentional ingestions from cough and cold medications in children","volume":"38","author":"Wang","year":"2022","journal-title":"Pediatr Emerg Care"},{"key":"10.1016\/j.amepre.2023.01.011_bib0026","unstructured":"U.S. Food and Drug Administration. Restricted delivery systems: flow restrictors for oral liquid drug products: draft guidance for industry. Silver Spring, MD: U.S. Food and Drug Administration.https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/restricted-delivery-systems-flow-restrictors-oral-liquid-drug-products-guidance-industry. Published March 2020. Accessed November 3, 2022."},{"issue":"1","key":"10.1016\/j.amepre.2023.01.011_bib0027","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6501e1","article-title":"CDC guideline for prescribing opioids for chronic pain - United States, 2016 [published correction appears in MMWR Recomm Rep. 2016;65(11):295]","volume":"65","author":"Dowell","year":"2016","journal-title":"MMWR Recomm Rep"},{"issue":"1","key":"10.1016\/j.amepre.2023.01.011_bib0028","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1542\/peds.2012-2978","article-title":"Adult prescription drug use and pediatric medication exposures and poisonings","volume":"132","author":"Burghardt","year":"2013","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.amepre.2023.01.011_bib0029","doi-asserted-by":"crossref","first-page":"299","DOI":"10.7326\/M21-3042","article-title":"Change in per capita opioid prescriptions filled at retail pharmacies, 2008\u20132009 to 2017\u20132018","volume":"175","author":"Stein","year":"2022","journal-title":"Ann Intern Med"},{"issue":"11","key":"10.1016\/j.amepre.2023.01.011_bib0030","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1001\/jamapsychiatry.2019.2563","article-title":"Opioid and benzodiazepine coprescribing in the United States before and after U.S. Food and Drug Administration boxed warning","volume":"76","author":"Zhang","year":"2019","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.amepre.2023.01.011_bib0031","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.jpeds.2019.12.027","article-title":"Circumstances involved in unsupervised solid dose medication exposures among young children","volume":"219","author":"Agarwal","year":"2020","journal-title":"J Pediatr"},{"issue":"5","key":"10.1016\/j.amepre.2023.01.011_bib0032","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/j.jpeds.2013.06.058","article-title":"Root causes, clinical effects, and outcomes of unintentional exposures to buprenorphine by young children","volume":"163","author":"Lavonas","year":"2013","journal-title":"J Pediatr"},{"issue":"6","key":"10.1016\/j.amepre.2023.01.011_bib0033","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2017-4232","article-title":"Unit-dose packaging and unintentional buprenorphine-naloxone exposures","volume":"141","author":"Wang","year":"2018","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.amepre.2023.01.011_bib0034","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s40264-019-00883-6","article-title":"The role of unit-dose child-resistant packaging in unintentional childhood exposures to buprenorphine-naloxone tablets","volume":"43","author":"Hampp","year":"2020","journal-title":"Drug Saf"},{"issue":"4","key":"10.1016\/j.amepre.2023.01.011_bib0035","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.emc.2004.05.004","article-title":"Deadly pediatric poisons: nine common agents that kill at low doses","volume":"22","author":"Michael","year":"2004","journal-title":"Emerg Med Clin North Am"},{"key":"10.1016\/j.amepre.2023.01.011_bib0036","unstructured":"Pill protect QuickFire challenge: designing for medication safety. Johnson & Johnson. https:\/\/jnjinnovation.com\/innovation-challenges\/pill-protect-quickfire-challenge-designing-medication-safety. Updated 2021. Accessed November 3, 2022."},{"issue":"5","key":"10.1016\/j.amepre.2023.01.011_bib0037","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1001\/jama.2021.23652","article-title":"Trends in use of melatonin supplements among U.S. adults, 1999\u20132018","volume":"327","author":"Li","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.amepre.2023.01.011_bib0038","unstructured":"Jackson KD, Howie LD, Akinbami LJ. Trends in allergic conditions among children: United States, 1997-2011. NCHS Data Brief. 2013;121:1\u20138. https:\/\/www.cdc.gov\/nchs\/data\/databriefs\/db121.pdf. Accessed November 3, 2022."}],"container-title":["American Journal of Preventive Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749379723000119?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749379723000119?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T08:09:26Z","timestamp":1760083766000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0749379723000119"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S0749379723000119"],"URL":"https:\/\/doi.org\/10.1016\/j.amepre.2023.01.011","relation":{},"ISSN":["0749-3797"],"issn-type":[{"value":"0749-3797","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trends in Emergency Department Visits for Unsupervised Pediatric Medication Exposures","name":"articletitle","label":"Article Title"},{"value":"American Journal of Preventive Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amepre.2023.01.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of American Journal of Preventive Medicine.","name":"copyright","label":"Copyright"}]}}